+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Japan Tuberculosis Diagnosis and Treatment Market 2019-2025

  • ID: 5116830
  • Report
  • February 2020
  • Region: Japan
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton, Dickinson and Co.
  • Eiken Chemical Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Labatec Pharma SA
Japan Tuberculosis Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Drugs Type (First Line Drugs and Second Line Drugs) By Diagnosis (Laboratory Testing, Nucleic Acid Amplification Test, Mantoux test, Radiography and Drug Susceptibility Testing) Forecast period (2019-2025).

Japan tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 1.2% during the forecast period. Public health centers in Japan are local government authorities responsible for public health in Japan. Their responsibilities included recommendation to admit infectious TB patients to an isolation ward. Additionally, it included health checkups with chest X-ray of those in a close contact with infectious TB patients. Moreover, public subsidy of medical expenses for TB treatments facing the emergence of multi-drug resistant tuberculosis (MDR-TB) was the part of it. Furthermore, when compared to other countries such as US where the rate is 3.1, 4.7 in Canada, and 5.5 in the Netherlands and 5.9 in Sweden, Japan is still considered as a medium-burden tuberculosis country. Being a medium-burden tuberculosis country, high demand of diagnosis and treatment motivates the market in the country. Moreover, Otsuka, one of the key players in Japan known for developing drugs discovered and developed a new drug, delamanid that has demonstrated its efficacy against multidrug-resistant Mycobacterium tuberculosis (MDR-TB).

Japan tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.

The key players that are active in the market include Abbott Laboratories, Becton, Dickinson and Co., Biochemical and Synthetic Products Pvt Ltd, Eiken Chemical Co., Ltd., F. Hoffmann-La Roche Ltd., Labatec Pharma SA, Lupin Pharmaceuticals, Inc., Otsuka Pharmaceutical Co, Ltd., Thermo Fisher Scientific and GlaxoSmithKline PLC. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.

Research Methodology:

The market study of the Japan Tuberculosis Diagnosis and Treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Japan Tuberculosis Diagnosis and Treatment Market Research and Analysis by Drugs Type
2. Japan Tuberculosis Diagnosis and Treatment Market Research and Analysis by Diagnosis

The Report Covers:
  • Comprehensive Research Methodology of the Japan Tuberculosis Diagnosis and Treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Japan Tuberculosis Diagnosis and Treatment market.
  • Insights about market determinants which are stimulating the Japan Tuberculosis Diagnosis and Treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Becton, Dickinson and Co.
  • Biochemical and Synthetic Products Pvt Ltd.
  • Eiken Chemical Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Labatec Pharma SA
  • Lupin Pharmaceuticals, Inc.
  • Otsuka Pharmaceutical Co, Ltd.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown